ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,562Medicare Part D Prescriptions Filled, Including Refills
$596K Total Retail Price of All Prescriptions
412 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 444 334
HYDROCODONE-ACETAMINOPHEN 418 276 S3
OMEPRAZOLE 290 231
SIMVASTATIN 265 223
METOPROLOL TARTRATE 204 131
LISINOPRIL 192 128
AMLODIPINE BESYLATE 190 154
NEXIUM 179 104
MELOXICAM 164 141
FUROSEMIDE 160 118
METFORMIN HCL 148 103
POTASSIUM CHLORIDE 147 112
SERTRALINE HCL 145 133
AZITHROMYCIN 121 73
GABAPENTIN 120 79
PRAVASTATIN SODIUM 117 83
PREDNISONE 116 93
WARFARIN SODIUM 107 59
TAMSULOSIN HCL 105 103
ZOLPIDEM TARTRATE 99 60
CRESTOR 96 75
CARVEDILOL 94 69
SPIRONOLACTONE 92 67
BISOPROLOL-HYDROCHLOROTHIAZIDE 91 60
ROPINIROLE HCL 86 52
DIGOXIN 85 73
PROAIR HFA 83 50
LOSARTAN POTASSIUM 81 59
AMITRIPTYLINE HCL 81 14 R
CIPROFLOXACIN HCL 79 70
TORSEMIDE 75 51
ADVAIR DISKUS 74 52
ALLOPURINOL 72 39
SYNTHROID 70 70
CLOPIDOGREL 69 47
GLYBURIDE 68 27 R
METOPROLOL SUCCINATE 68 57
TRAMADOL HCL 68 41
ACETAMINOPHEN-CODEINE 68 26 S3
PAROXETINE HCL 67 67
ATENOLOL 66 49
HYDROCHLOROTHIAZIDE 65 43
DEXILANT 64 21
IBUPROFEN 62 15
LYRICA 60 21
HYDRALAZINE HCL 60 39
SINGULAIR 56 46
KLOR-CON M20 56 31
CITALOPRAM HBR 55 28
LANTUS SOLOSTAR 53 45
PLAVIX 53 38
NAPROXEN 52 35
PRADAXA 52 40
FLUTICASONE PROPIONATE 52 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.